Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.09
-0.1400-0.81%
Post-market: 17.090.00000.00%17:46 EDT
Volume:934.26K
Turnover:16.04M
Market Cap:3.16B
PE:-10.55
High:17.35
Open:17.12
Low:16.96
Close:17.23
52wk High:45.30
52wk Low:16.24
Shares:184.69M
Float Shares:81.38M
Volume Ratio:0.79
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6200
EPS(LYR):-1.6200
ROE:-29.06%
ROA:-5.01%
PB:3.15
PE(LYR):-10.55

Loading ...

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jan 21

FDA draft guidance favorable for Legend Biotech, says RBC Capital

TIPRANKS
·
Jan 21

U.S. RESEARCH ROUNDUP-Boeing, Goldman Sachs, PNC Financial Services

Reuters
·
Jan 19

Piper Sandler Remains a Buy on Legend Biotech (LEGN)

TIPRANKS
·
Jan 15

Legend Biotech Signals 2026 Profitability Push and CARVYKTI Expansion in Updated J.P. Morgan Presentation

TIPRANKS
·
Jan 15

Legend Biotech (LEGN) Is Up 7.6% After Scaling CARVYKTI Output And Targeting 2026 Profitability - Has The Bull Case Changed?

Simply Wall St.
·
Jan 14

Legend Biotech Showcases Growth and Pipeline Progress at J.P. Morgan Healthcare Conference

Reuters
·
Jan 12

Legend Biotech Highlights Recent Business Updates at 44TH Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
Jan 12

Former Legend Biotech VP Pan Qi Joins Shuimu Molecular as Chief Biomedical Scientist

Deep News
·
Jan 09

Legend Biotech Corp : RBC Cuts Target Price to $66 From $74

THOMSON REUTERS
·
Jan 08

Oppenheimer Initiates Legend Biotech at Outperform With $75 Price Target

MT Newswires Live
·
Jan 07

Legend Biotech's Stock Plummets 50% in Half a Year: A Valuation Trap or a Golden Opportunity?

Stock News
·
Jan 07

Legend Biotech Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Dec 17, 2025

Legend Biotech Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Dec 13, 2025

Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says

MT Newswires Live
·
Dec 11, 2025

Cancer Study Buoys These Small Biotechs -- Barrons.com

Dow Jones
·
Dec 10, 2025

HK Stock Movement | GENSCRIPT BIO (01548) Extends Losses by Over 11% in Afternoon Session as Affiliate Legend Biotech Drops 7% Overnight

Stock News
·
Dec 09, 2025

Legend Biotech Is Maintained at Buy by UBS

Dow Jones
·
Dec 08, 2025

UBS Adjusts Legend Biotech Price Target to $48 From $54, Maintains Buy Rating

MT Newswires Live
·
Dec 08, 2025

Legend Biotech Reports CARVYKTI® Delivers Median PFS of 50.4 Months in Multiple Myeloma Trial

Reuters
·
Dec 08, 2025